Cognition Therapeutics Inc
CGTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001455365
No open-market purchases or sales by Cognition Therapeutics Inc insiders were filed in the last 90 days; 66 institutions reported holding it in 13F filings for Q2 2026, worth $26.0M in total; no superinvestor holds it.
Holders of 5% or more of CGTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cognition Therapeutics Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BIOS Memory SPV I, LP | 13D/A | 6.90%6.06M shares | – | Sep 23, 20251 filing | Sep 23, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Cognition Therapeutics Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 23, 20259:58 PM ET | BIOS Memory SPV I, LPand 21 others | 13D/A | 6.90%6.06M shares | – | Sep 19, 2025 | SEC |
| Feb 4, 202510:29 AM ET | Pathstone Family Office, LLC | 13G | 0.00%0 shares | NewBelow 5% | May 23, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Cognition Therapeutics Inc shares.
No Form 144 notices for Cognition Therapeutics Inc are on file.